ライフサイエンスコーパス: Germany

1 therlands, Denmark, Israel, Switzerland, and Germany).

2 ter 500 or 700 (Carl Zeiss Meditec AG, Jena, Germany).

3 ystem (Pulsion Medical Systems, Feldkirchen, Germany).

4 ed from the LUPE cohort (2015-2016, Bavaria, Germany).

5 the Steinbruch Schmidt F-F boundary section (Germany).

6 er a 4.7 km reach of the River Erpe (Berlin, Germany).

7 ctralis (Heidelberg Engineering, Heidelberg, Germany).

8 2R (Photoscreener PlusoptiX Inc., Nuremberg, Germany).

9 munology and Epigenetics (MPI-IE), Freiburg, Germany).

10 oftware (Heidelberg Engineering, Heidelberg, Germany).

11 T (Heidelberg Engineering, Inc., Heidelberg, Germany).

12 technology, Gene Center, LMU Munich, Munich, Germany).

13 Cardiovascular Disease miRNA array (Qiagen, Germany).

14 n with EyeSi(R) Surgical (VRMagic, Mannheim, Germany).

15 lis; Heidelberg Engineering Co., Heidelberg, Germany).

16 OF Biotyper system (Bruker Daltonik, Bremen, Germany).

17 GenoType CM/AS (Hain Lifescience, Tubingen, Germany).

18 ctralis (Heidelberg Engineering, Heidelberg, Germany).

19 lis OCT (Heidelberg Engineering, Heidelberg, Germany).

20 HRA-OCT; Heidelberg Engineering, Heidelberg, Germany).

21 system (Heidelberg Engineering, Heidelberg, Germany).

22 ctralis; Heidelberg Engineering, Heidelberg, Germany).

23 t with primary chemotherapy from Heidelberg, Germany.

24 was installed at a coal-fired power plant in Germany.

25 Germany, and TolerogenixX GmbH, Heidelberg, Germany.

26 pha (anti-TNFalpha) in UC and CD patients in Germany.

27 016 from randomly selected OST facilities in Germany.

28 tion traps from different riverine points in Germany.

29 tion remains a frequent finding among MSM in Germany.

30 deral Ministry for Education and Research of Germany.

31 tery bypass grafting (CABG) at 12 centers in Germany.

32 at the University Eye Hospital in Tubingen, Germany.

33 abidopsis lines that were grown in Spain and Germany.

34 velocity at a local scale (1 x 1 km) across Germany.

35 t of face masks on the spread of COVID-19 in Germany.

36 ow at the Institute of Virology in Wurzburg, Germany.

37 nduced ALF in the University Hospital Essen, Germany.

38 ral and southern France, Spain, and southern Germany.

39 ots of the HIV transmission in Cologne-Bonn, Germany.

40 en 2003 and 2007 in multiple institutions in Germany.

41 Function, Inflammation and Ageing cohort in Germany.

42 ssland managed at low intensity in southwest Germany.

43 ne (HZ) of an urban lowland river in Berlin, Germany.

44 uly-August 2016 in a rural area in southwest Germany.

45 se diseases (controls) from a tissue bank in Germany.

46 olithic to the Middle Bronze Age in southern Germany.

47 s in policy measures across the 16 states of Germany.

48 renal services in 16 hospitals in the UK and Germany.

49 undance in northeastern than in southwestern Germany.

50 he United States and the Messel Formation of Germany.

51 HSCT centres based in the USA, Denmark, and Germany.

52 ific populations of liver transplantation in Germany.

53 modium falciparum transmission in nonendemic Germany.

54 ient or outpatient rehabilitation centres in Germany.

55 University Hospital Regensburg, Germany.

56 male earnings in the nursing labor market in Germany.

57 ohlenstein-Stadel (HST) cave in southwestern Germany.

58 , in Nijmegen, the Netherlands, and Cologne, Germany.

59 ary wastewater effluent from a major city in Germany.

60 reasing incidence of keratinocyte cancers in Germany.

61 ed in a neonatal tertiary referral center in Germany.

62 ensity instrument at the European XFEL GmbH, Germany.

63 n who died at a university medical center in Germany.

64 o 2014) from a statutory health insurance in Germany.

65 prescribing for 9751 inhabitants of Leipzig, Germany.

66 second most common cause of cancer death in Germany.

67 Ophthalmology, Goethe University, Frankfurt, Germany.

68 ation in the Russian Federation, Poland, and Germany.

69 stria, and the Mannheim University Hospital, Germany.

70 from a population-based cohort from Southern Germany.

71 s the largest medical society in present-day Germany.

72 87% of patients with the CEP290 mutation in Germany.

73 hort study at ten academic clinical sites in Germany.

74 Ophthalmology, Goethe University, Frankfurt/Germany.

75 d the lowest rates in South Korea (1.6%) and Germany (0.7%).

76 a (652 refugees), Austria (150), China (65), Germany (1,104), Italy (297), Lebanon (646), Nepal (574)

77 produced the most articles (16), followed by Germany (13 articles), and China (7 articles).

78 Europe also, as France already had 12 cases, Germany 16, the UK 9, Italy 3, Spain 2 and other countri

79 at 64 hospitals across the United States and Germany (2006-2015).

80 Tollense Bronze Age battlefield in northern Germany (~3,200 before present, BP), the oldest large-sc

81 using the VisuMax (Carl Zeiss Meditec, Jena, Germany) 500-kHz femtosecond laser system.

82 ased sample of 578 individuals from Northern Germany (57% male, median age 62 y), diet was assessed w

83 ls, tantalum and copper, within the scope of Germany, a leader in recycling.

84 Among children aged 2 to 5 years in Bavaria, Germany, a program of primary care-based screening showe

85 ll study, a population-based cohort study in Germany (age at first follow-up 50-80 years, mean follow

86 A laboratory experiment conducted in Germany aimed to separate the effect of recalling violen

87 y tract (LRT) panel (Curetis, Holzgerlingen, Germany) allows the multiplexed rapid detection and iden

88 ffected more than 35,000 farms in France and Germany alone.

89 For Germany, an annual wet deposition flux of 190 mug/m(2) o

90 study of hospitals and private practices in Germany and Austria encompassing 1961 adults with commun

91 iversity experiments (the Jena Experiment in Germany and BioDIV in the United States) in terms of the

92 ter effluent contributions in streams across Germany and consequences for indirect drinking water abs

93 independent samples from Hong Kong, Austria, Germany and Denmark.

94 e used data from a 9-y longitudinal study in Germany and examined the similarity between an individua

95 ity "deserts" were identified in Czechia and Germany and for durum wheat in southern Europe.

96 ent introductory events from Italy, Austria, Germany and France followed by local amplification in, a

97 ---China, South Korea, Italy, Spain, Brazil, Germany and France, and the numerical results showed tha

98 placental and marsupial animals at a zoo in Germany and in wild yellow-necked field mice (Apodemus f

99 in postmenopausal breast cancer survivors in Germany and investigated associations between postdiagno

100 his approach to selected regions in the USA, Germany and Iran to evaluate the current aquifer regime.

101 x for the United Kingdom, the United States, Germany and Italy, indicating relative happiness in resp

102 approaching MHz such as the European XFEL in Germany and LCLS-II in the USA, as well as by utilizing

103 s and archaeological excavations in southern Germany and north-eastern France, dating between 300 and

104 r level (GWL) fluctuations for south-western Germany and north-eastern France.

105 g subtype A infections, has been observed in Germany and other European countries.

106 Recent studies from Germany and Puerto Rico suggest that insects may be in a

107 w LP in all three regions, i.e., in northern Germany and South-eastern and Eastern Europe, suggesting

108 ippines, and only prostitution is allowed in Germany and Spain.

109 Records from 4 centres in Germany and Sweden were reviewed to select eyes with age

110 assessed general public attention in France, Germany and the United Kingdom toward climate change and

111 ng BNT162b1 in younger adults from trials in Germany and the United States, support the selection of

112 have been reported previously from trials in Germany and the United States.

113 troductions of the virus from taking hold in Germany and the United States.

114 in Germany) and three validation cohorts (in Germany and the USA) of patients with acute GVHD who had

115 cords of a level III neonatal care center in Germany and were collected between 2013 and 2019.

116 veloped in Western countries (United States, Germany) and appeals to individualist tendencies, which

117 rm (Technolas Bausch and Lomb (B&L), Munich, Germany) and conventional phacoemulsification cataract s

118 ily basis for 4 consecutive years in Munich (Germany) and Davos (Switzerland).

119 ne at Charite Research Organisation (Berlin, Germany) and included men and women (aged 18-60 years, i

120 ailable test (AdnaTest BreastCancer, Qiagen, Germany) and our previously described multiplex quantita

121 IOLMaster 500 (Carl Zeiss Meditec AG, Jena, Germany) and Pentacam (OCULUS Inc, Arlington, WA) device

122 analysis, we analysed a training cohort (in Germany) and three validation cohorts (in Germany and th

123 contamination in gases from Iceland, Eifel (Germany) and Yellowstone (USA), we derive estimates of m

124 imaging using the Pentacam (Oculus, Wetzlar, Germany), and completed a health questionnaire.

125 m((R)) platform (Millipore Sigma, Darmstadt, Germany), and confocal images of an in vivo mouse diseas

126 (San Diego, CA), Euroimmun (Lubeck, Germany), and Ortho-Clinical Diagnostics (Rochester, NY)

127 nfluences on Allergy Development (GINIplus) (Germany), and Prevention and Incidence of Asthma and Mit

128 linic (Jacksonville, FL, USA) and in Munich (Germany), and the University College London PSP cohort,

129 l done in eight institutions across the USA, Germany, and Belgium, lungs from extended-criteria donor

130 The armies of the United Kingdom, Germany, and France undertook important work on the tran

131 ur European countries (England, Switzerland, Germany, and France).

132 9th century, focusing on the United Kingdom, Germany, and France.

133 e samples from the United States, France and Germany, and in a study testing attitudes about a medica

134 vars were grown in a greenhouse in Erlangen, Germany, and in the field in Ibadan, Nigeria.

135 astroenterology practices and 4 hospitals in Germany, and included 2422 men and women aged 40 to 80 y

136 enome-wide association studies from Finland, Germany, and Korea, we used a data-driven machine learni

137 shallow STE on Spiekeroog Island, North Sea, Germany, and linked our findings to trace metal and nutr

138 England, p=0.26 for Switzerland, p=0.23 for Germany, and p=0.037 for France).

139 England, p=0.54 for Switzerland, p=0.52 for Germany, and p=0.40 for France), and for all assessed co

140 We used data from panel studies in Augsburg, Germany, and Rochester, New York, USA, and two controlle

141 highest rates of anxiety in respondents from Germany, and social exclusion and isolation most common

142 m four European countries (Denmark, Estonia, Germany, and Sweden).

143 y at academic medical centres, in Australia, Germany, and the USA.

144 , Australia, Canada, Poland, Italy, Ukraine, Germany, and the USA.

145 for Economic Affairs and Technology, Berlin, Germany, and TolerogenixX GmbH, Heidelberg, Germany.

146 Applying our framework to Germany as a proof of concept, we show significant losse

147 les from Bell Beaker and Unetice contexts in Germany, as well as Bronze Age Bulgaria.

148 cladina I-4A) and Hohlenstein-Stadel Cave in Germany, as well as to a ~60,000- to 70,000-y-old Neande

149 E were collected prospectively in centers in Germany, Austria, and Switzerland, during 4.5 years.

150 to six regions in Europe: Austria, Bavaria (Germany), Baden-Wurttemberg (Germany), Lombardy (Italy),

151 d from 14 countries (US, Australia, Belarus, Germany, Belgium, Denmark, Finland, Norway, Canada, Pola

152 listed on the TraumaRegister DGU (TR-DGU) in Germany between 2002 and 2015 aged 16 years or older and

153 children aged 1.75 to 5.99 years in Bavaria, Germany, between 2015 and 2019 by primary care pediatric

154 econdary hospitals in Switzerland, Bulgaria, Germany, Brazil, and Spain.

155 in UBAP1 in affected persons from Iran, USA, Germany, Canada, Spain, and Bulgarian Roma.

156 from London (UK; cohorts 1 and 2), Giessen (Germany; cohort 3), and Paris (France; cohort 4).

157 effluents from a chemical-industrial area in Germany, collected by the passive sampler Blue Rayon.

158 vate practice sites in the United States and Germany, conducted between December 2016 and November 20

159 large population-based case-control study in Germany (Darmkrebs: Chancen der Verhutung durch Screenin

160 milial Breast and Ovarian Cancer in Cologne, Germany; data analysis, November 1 through December 31,

161 SD-OCT; Heidelberg Engineering, Heidelberg, Germany) demonstrated the highest positive percent agree

162 Saarland University Medical Centre (Homburg, Germany; derivation cohort) and those undergoing electiv

163 a hand-held non-mydriatic (Visuscout 100(R)-Germany) digital retinal camera.

164 ents at time of type 1 diabetes diagnosis in Germany during the first 2 months of the coronavirus dis

165 ng difluoro congener, DFDT, was developed in Germany during World War II, but in 1945 Allied inspecto

166 tal MI cases from a MI registry in Augsburg, Germany, during 2005-2015.

167 such as the "Therapy Allergen Ordinance" in Germany; (e) optimization of trial design in AIT clinica

168 e (Hungary and United Kingdom) and positive (Germany) effects during crop flowering.

169 cements and migration: deportation into East Germany, escape to the West, and emigration to the Unite

170 ity of Helsinki) were followed by 6 years in Germany (European Molecular Biology Laboratory), 16 year

171 and Research Training in Human Reproduction, Germany Federal Ministry of Health, National Health and

172 50 years of age living in a model region in Germany (federal state of Bavaria, 3.5 million inhabitan

173 d, the Netherlands, the USA, Taiwan, the UK, Germany, Finland, Australia, Sweden, and France), with b

174 n remains from 21 sites in Austria, Britain, Germany, France, and Spain for Y. pestis DNA and reconst

175 to April-30-20, for the countries of Italy, Germany, France, and Spain.

176 at 92 hospitals in England, Scotland, Wales, Germany, France, and Sweden.

177 3 trial, was done in 159 academic centres in Germany, France, Australia, Austria, and the UK.

178 the most, with the United Kingdom, Ireland, Germany, France, the Netherlands, and Denmark as most af

179 a set from the Federal statistical Office of Germany from 1 January 2007 through 31 December 2015 and

180 s for the four European countries (including Germany from a previous publication) analyzed so far.

181 Crohn's disease [CD]; 236 male), enrolled in Germany from August 2013 through April 2014 and followed

182 erwent upper and lower GI tract endoscopy in Germany from December 2015 through September 2016.

183 a, Belgium, Canada, Czech Republic, Denmark, Germany, Greece, Ireland, Israel, Italy, Poland, Portuga

184 4 study sites in Australia, Austria, Canada, Germany, Greece, Ireland, Japan, the UK, and the USA, hy

185 a, Czech Republic, Denmark, Estonia, France, Germany, Greece, Italy, Israel, Luxembourg, Poland, Port

186 to 12 EDs in 8 European countries (Austria, Germany, Greece, Latvia, the Netherlands [n = 3], Spain,

187 ised, controlled trials at 14 study sites in Germany, Greece, Romania, and Turkey.

188 mobile phone users to show that mobility in Germany has not only been reduced considerably: Lockdown

189 Ireland, England, the Netherlands, Belgium, Germany (Hesse), Malta, the United States, and Chile wer

190 aminated former industrial site in southwest Germany, Hg isotope analysis was combined with an invest

191 ial in 31 transplantation centres in France, Germany, Hungary, Italy, and Poland.

192 countries (Belgium, Czech Republic, France, Germany, Hungary, Italy, Netherlands, Poland, Spain, and

193 es (Belgium, Canada, Czech Republic, France, Germany, Hungary, Japan, the Netherlands, South Korea, S

194 tudy done at 41 sites in the Czech Republic, Germany, Hungary, Poland, Russia, and the USA.

195 (Australia, Canada, Czech Republic, France, Germany, Hungary, Poland, Spain, and the USA), eligible

196 end the understanding of the HIV epidemic in Germany.IMPORTANCE HIV-1 subtype A is the second most pr

197 Schmallenberg virus (SBV) was discovered in Germany in late 2011 and then spread rapidly to many Eur

198 evice (Pulsion Medical Systems, Feldkirchen, Germany) in whom fluid expansion was planned, with (intr

199 CCO-2; Pulsion Medical Systems, Feldkirchen, Germany), in whom fluid administration was planned were

200 ng a consensus conference in Frankfurt/Main, Germany, in April 2018.

201 Tissue Architecture' was held in Heidelberg, Germany, in March 2019, with 150 participants seeking to

202 cases of hemolytic uremic syndrome (HUS) in Germany, including 90 children.

203 nomes of an Early and End Neolithic dog from Germany, including a sample associated with an early Eur

204 the data from two countries (South Korea and Germany) indicate the effectiveness of our approach, com

205 gislative materials of the United States and Germany into cluster families that reflect legal topics.

206 oss 15 countries (Australia, Canada, France, Germany, Ireland, Israel, Italy, Japan, New Zealand, Nor

207 ren with food allergy and distributed across Germany, Ireland, Netherlands, Spain and UK via patient

208 t 13 hospitals in Argentina, Austria, China, Germany, Ireland, New Zealand, Singapore, and the USA.

209 opean countries: the United Kingdom, France, Germany, Ireland, Spain, Italy, Denmark and the Netherla

210 and HCV incidence rates confirm that OST in Germany is an effective setting both for treating chroni

211 L0045) of Julius Kuhn-Institut collection in Germany is highly resistant to fire blight disease, inci

212 oss 11 countries (Australia, Canada, France, Germany, Israel, Italy, Japan, New Zealand, Norway, Spai

213 tries worldwide (Australia, Belgium, France, Germany, Israel, Italy, New Zealand, Portugal, South Kor

214 ocated in Australia, Brazil, Canada, France, Germany, Israel, Italy, South Korea, Sweden, the UK, and

215 from 52 clinical centres in Canada, France, Germany, Israel, Italy, Spain, the UK, and the USA.

216 , in patients with PKAN in four hospitals in Germany, Italy, England, and the USA.

217 Australia, Austria, Belgium, Canada, France, Germany, Italy, Japan, Norway, Spain, and the USA.

218 90 hospitals and cancer centres in Denmark, Germany, Italy, Japan, South Korea, Taiwan, the UK, and

219 ry care centres in Denmark, Estonia, France, Germany, Italy, Latvia, Lithuania, Romania, South Africa

220 tries; Australia, Argentina, Canada, France, Germany, Italy, Mexico, Russia, South Africa, South Kore

221 omen aged 18-87 years in the Czech Republic, Germany, Italy, Norway, and the UK.

222 Australia, Austria, Canada, Denmark, France, Germany, Italy, Poland, Russia, the Netherlands, the UK,

223 ysis of COVID-19 data from countries such as Germany, Italy, Spain and United Kingdom, obtaining very

224 countries (the USA, Canada, Belgium, France, Germany, Italy, Spain, and Israel).

225 ) and European Union 5 ([EU5]; i.e., France, Germany, Italy, Spain, and the United Kingdom) data from

226 ere IBS-C in six European countries (France, Germany, Italy, Spain, Sweden and the UK).

227 entres across nine countries (Brazil, China, Germany, Italy, Spain, the Netherlands, the UK, the USA,

228 inics in Australia, Belgium, Canada, France, Germany, Italy, Taiwan, the USA, and the UK into seven c

229 s done in Australia, Brazil, Canada, France, Germany, Italy, the Netherlands, Peru, Poland, Romania,

230 he Czech Republic, Denmark, Finland, France, Germany, Italy, the Netherlands, Poland, Spain, Sweden,

231 nternationally at eight hospitals in France, Germany, Italy, the UK, and the USA (60 week follow-up).

232 Industrialized countries (USA, UK, Germany, Japan, Italy, France and Canada) were the most

233 s at 24 sites in seven countries (Australia, Germany, Japan, Spain, Turkey, the USA, and the UK).

234 stria, Bavaria (Germany), Baden-Wurttemberg (Germany), Lombardy (Italy), Spain, and Switzerland.

235 ctralis (Heidelberg Engineering, Heidelberg, Germany) macular spectral-domain (SD) OCT imaging.

236 panel includes more than 1,300 samples from Germany, Malta, China, India, Iran, Japan and Korea and

237 Hepato-Pancreato-Biliary Association (Mainz, Germany, May 23-26, 2017) an expert meeting "10th annive

238 t; Bayer Healthcare Pharmaceuticals, Berlin, Germany) MRI (7.98/3.72) of regions similar to those in

239 t; Bayer Healthcare Pharmaceuticals, Berlin, Germany) MRI (7.98/3.72) of regions similar to those in

240 cohorts of elderly from the Netherlands and Germany (n = 13,044).

241 States (n = 85), followed by Canada (n = 7), Germany (n = 5), and Italy (n = 5).

242 dependent patient cohorts (Glasgow, n = 198; Germany, n = 468).

243 These fossils were collected at two sites in Germany, Neumark-Nord and Weimar-Ehringsdorf, and likely

244 s morhua) specimens from excavation sites in Germany, Norway, and the United Kingdom.

245 re, and South Korea) and four in Europe (ie, Germany, Norway, Spain, and the UK).

246 pathways and limited upward job mobility in Germany, nurses tend to be more homogenous in their moti

247 rces in Development' was held in Heidelberg, Germany, on 3-6 July 2019.

248 s to lower mortality rates in countries like Germany or South Korea.

249 ites across nine countries (Belgium, France, Germany, Poland, Netherlands, South Korea, Spain, the UK

250 centres in Austria, Czech Republic, France, Germany, Poland, Slovakia, and Switzerland.

251 Germany, Poland, Sweden, and Estonia showed increasing n

252 le of 319 asparagus samples originating from Germany, Poland, the Netherlands, Greece, Spain, China a

253 sex stratified CMV prevalence statistics for Germany, Poland, UK, and Chile.

254 Our model finds that in Germany policies that mandated contact restrictions (e.g

255 of refugees into Europe and especially into Germany, raising the question of whether the surge in no

256 t water chlorination processes in France and Germany, resulting in different ClxBPA exposure levels,

257 who have sex with men (HIV-infected MSM) in Germany rose before HCV direct-acting antivirals (DAAs).

258 Germany's largest drinking water reservoir was sampled f

259 ystem is not as cost-effective as in some of Germany's neighbouring countries, which, given present e

260 lmology centers: Toronto, Canada; Frankfurt, Germany; Salzburg, Austria; and Leuven, Belgium.

261 enters in the United States, United Kingdom, Germany, Saudi Arabia, Singapore, and Israel (Group 1),

262 ctral-domain OCT (Cirrus; Zeiss, Oberkochen, Germany) scans were obtained and analyzed using a novel

263 mograph (Heidelberg Engineering, Heidelberg, Germany) scores over time.

264 (ZBSA), Albert-Ludwigs-University, Freiburg, Germany" should have been "Life Imaging Center, Center f

265 of three independent IPF cohorts: Freiburg (Germany), Siena (Italy), and Leuven (Belgium) including

266 st common European hantaviruses from France, Germany, Slovenia and Finland, such as Puumala virus, Do

267 hase 3 study at 40 sites in Belgium, Canada, Germany, South Africa, Spain, and the USA.

268 Croatia, Georgia, Hungary, Ukraine, France, Germany, South Africa, the UK, and the USA).

269 , hospitals, and clinics in the USA, France, Germany, Spain, and the UK.

270 We study popular attitudes in Germany, Spain, the Philippines, and the United States t

271 In Germany, subtype A belongs to the most abundant non-B su

272 ollowed up at 6 clinical centers in Finland, Germany, Sweden, and the United States.

273 adults with advanced cancers at 22 sites in Germany, Switzerland, South Korea, Singapore, Spain, and

274 t two temporally separate events in Southern Germany that, thus, witnessed a double disaster in the M

275 it was developed to support HIV research in Germany, the feature set and language options, allow muc

276 ed with variants in MLH1, MSH2, or MSH6 from Germany, the Netherlands, and Finland who received at le

277 ruited at 20 tertiary heart valve centres in Germany, the Netherlands, Switzerland, and the UK.

278 uded in the MSIDETECT consortium study, from Germany, the Netherlands, the United Kingdom, and the Un

279 European countries (Italy, France, Holland, Germany, the UK, and Spain).

280 wo consecutive Islamist terrorist attacks in Germany, the Wurzburg and Ansbach attacks, in July 2016.

281 a from 3 case-control studies carried out in Germany: the Mammary Carcinoma Risk Factor Investigation

282 rospective study of 2 cohorts of patients in Germany; the discovery cohort comprised 12 patients with

283 alysis, Albert-Ludwigs-University, Freiburg, Germany." This change required some renumbering of subse

284 ently evaluated pollen and symptom data from Germany to examine the new definitions of the European A

285 cientific Software Development GmbH, Berlin, Germany) to process interview transcripts and the framew

286 m grassland biodiversity experiment in Jena, Germany, to examine how microbial physiology responds to

287 data of additional case/control samples from Germany, UK, and USA identified five variant carriers am

288 ticenter clinical trial in 26 centers across Germany was conducted between March 2016 and December 20

289 al working channel (AWC) (Ovesco, Tuebingen, Germany) was utilized for the EMR+ procedure, allowing a

290 federal legislation of the United States and Germany, we find impressive expansion in the size and co

291 the model to residential solar customers in Germany, we find that behind-the-meter storage is econom

292 e results of a survey in which scientists in Germany were asked about their attendance at conferences

293 In 2015, more than 50% of all ELS cases in Germany were performed in the context of cardiothoracic

294 Forty-four small streams in Germany were profiled during several rain events for the

295 the Cirrus HD-OCT system (Zeiss, Oberkochen, Germany) were included.

296 consecutive months at eight locations across Germany, were analyzed.

297 m the Teratology Information Service in Ulm, Germany, were received July 22, 2020.

298 ion of wintering Scaup in coastal Poland and Germany (where lack of effective implementation of conse

299 ce value of 4mg/kg of morphine set by BfR in Germany, whereas 25% of the samples did not comply with

300 orph from the Middle Triassic from Vellberg (Germany), which combines a mosaic of features from both